Arcoma ABOSTO:ARCOMA +6.95%75 FCF Yield % is 12.24 as of Jun. 30, 2026. GuruFocus rates OSTO:ARCOMA with a GF Score™ of 75/100 and a GF Value™ of kr7.85 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Arcoma AB ranks better than 96.14% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Arcoma AB's FCF Yield % or its related term are showing as below:
OSTO:ARCOMA'
s FCF Yield % Range Over the Past 10 Years
Min: -31.06 Med: -0.53 Max: 17.34
Current: 12.24
During the past 13 years, the highest FCF Yield % of Arcoma AB was 17.34%. The lowest was -31.06%. And the median was -0.53%.
OSTO:ARCOMA's FCF Yield % is ranked better than 96.14% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: -0.385
vs OSTO:ARCOMA: 12.24
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Arcoma AB FCF Yield % Related Terms
Arcoma AB FCF Yield % Historical Data
* Premium members only.
The historical data trend for Arcoma AB's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ARCOMA vs ABT, SYK, MDT: FCF Yield % Comparison
For the Medical Devices subindustry, Arcoma AB's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcoma AB FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Arcoma AB's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Arcoma AB's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arcoma AB (OSTO:ARCOMA) has a FCF Yield % of 12.24 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Arcoma AB and its competitors. According to the industry distribution chart, Arcoma AB ranks #33 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 3.9%.
Is Arcoma AB's FCF Yield % too high?
Arcoma AB's current FCF Yield % is 12.24. Based on the distribution chart, Arcoma AB ranks #33 out of 854 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Arcoma AB has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Arcoma AB's FCF Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Arcoma AB ranks #33 out of 854 companies for FCF Yield %. This places Arcoma AB in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Arcoma AB and its competitors. Arcoma AB's current FCF Yield % is 12.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcoma AB stock overvalued right now?
Based on GuruFocus' analysis, Arcoma AB (OSTO:ARCOMA) is currently considered Modestly Overvalued. The stock's GF Value™ is kr7.85, compared to a current price of kr8.92 — trading 13.6% above its estimated fair value. The current FCF Yield % is 12.24. Arcoma AB's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Arcoma AB (OSTO:ARCOMA), the current FCF Yield % is 12.24 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcoma AB (OSTO:ARCOMA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcoma AB stock appears to be overvalued.
The current stock price of kr8.92 is trading 13.6% above its estimated GF Value™ of kr7.85.
GuruFocus considers Arcoma AB to be Modestly Overvalued.
Key valuation signals for OSTO:ARCOMA:
FCF Yield %: 12.24
GF Value™: kr7.85 vs. price of kr8.92 (13.6% above fair value)
No single metric tells the full story. See the OSTO:ARCOMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
75GF Score
Get the complete analysis for OSTO:ARCOMA
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ARCOMA has been successfully added to your 
